Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 16,489-16,500 of 23,847
Drug study icon
CompletedNCT00868959

Lurasidone - A 24-week Extension Study of people with Bipolar I Depression

This study exists to explore whether the medication Patients could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

Multiple locations, including Little Rock
Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States, France, Canada, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00868452

Lurasidone - A 6-week Study of people with Bipolar I Depression (Add-on)

This study exists to explore whether the medication Patients could improve care and understanding. Researchers are trying to understand what the medication Patients could change in day-to-day care and decision-making.

Multiple locations, including Little Rock
Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, France, Czechia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00868699

Lurasidone - A 6-week Study of people with Bipolar I Depression (Monotherapy)

This study exists to explore whether the medication Patients could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

Multiple locations, including Escondido
Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, France, Czechia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT02147379

Lurasidone and Cognition in Bipolarity type I

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Vancouver
BipolarityDrugFrom 19 Years to 65 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Bipolarity
Drug study icon
CompletedNCT02199743

Lurasidone Effects on Tissue Glutamate in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Dallas
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Schizophrenia
Drug study icon
CompletedNCT01485640

Lurasidone Extended Use Study

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

Multiple locations, including Kelowna
Schizophrenia, BipolarityDrug
Countries
France, Canada, Colombia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT00615433

Lurasidone HCl A Phase 3 Study of people with Acute Schizophrenia

This study is completed in the United States, in Colombia, in India, .... It focuses on schizophrenia.

Multiple locations, including Little Rock
SchizophreniaDrugFrom 18 Years to 75 Years
Countries
United States, Colombia, India, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01821378

Lurasidone Low-Dose - High-Dose Study Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
SchizophreniaDrugFrom 18 Years to 75 Years
Countries
United States, Colombia, Romania, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.